Shockwave Medical, Inc.

Equities

SWAV

US82489T1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
325.6 USD +0.94% Intraday chart for Shockwave Medical, Inc. +14.15% +70.88%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shockwave Medical Insider Sold Shares Worth $1,150,680, According to a Recent SEC Filing MT
Global markets live: Apple, UBS, Microstrategy, Merck, Amazon... Our Logo
CL King Initiates ShockWave Medical With Buy Rating, Price Target is $368 MT
North American Morning Briefing : Stocks Edge Higher But Investor Caution Caps Gains DJ
News Highlights : Top Company News of the Day - Wednesday at 3 AM ET DJ
News Highlights : Top Company News of the Day - Wednesday at 1 AM ET DJ
News Highlights : Top Company News of the Day - Tuesday at 11 PM ET DJ
News Highlights : Top Company News of the Day - Tuesday at 9 PM ET DJ
News Highlights: Top Company News of the Day - Tuesday at 7 PM ET DJ
Health Care Climbs on Weight-Loss Drug Excitement -- Health Care Roundup DJ
News Highlights : Top Company News of the Day - Tuesday at 5 PM ET DJ
Sector Update: Health Care Stocks Advance Late Afternoon MT
Sector Update: Health Care MT
News Highlights: Top Company News of the Day - Tuesday at 3 PM ET DJ
Johnson & Johnson in Talks to Acquire Shockwave Medical MT
Johnson & Johnson in Talks to Acquire Shockwave Medical MT
Johnson & Johnson Reportedly in Talks to Acquire Shockwave Medical MT
Johnson & Johnson Reportedly Considers Deal for Shockwave Medical CI
Shockwave Medical Insider Sold Shares Worth $507,294, According to a Recent SEC Filing MT
Shockwave Medical Insider Sold Shares Worth $1,041,440, According to a Recent SEC Filing MT
UBS Raises Price Target on ShockWave Medical to $250 From $228, Maintains Neutral Rating MT
Sector Update: Health Care Stocks Higher Late Afternoon MT
ShockWave Medical's Shares Rise After Q4 Revenue Beat MT
Piper Sandler Raises ShockWave Medical's Price Target to $290 From $275, Keeps Overweight Rating MT
Needham Adjusts Price Target on ShockWave Medical to $286 From $260, Keeps Buy Rating MT
Chart Shockwave Medical, Inc.
More charts
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
322.6 USD
Average target price
266 USD
Spread / Average Target
-17.55%
Consensus
  1. Stock
  2. Equities
  3. Stock Shockwave Medical, Inc. - Nasdaq
  4. News Shockwave Medical, Inc.
  5. ShockWave Medical Earnings, Sales Increase in Q3; Lifts 2022 Revenue Guidance